.

Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System

Nano+™ Polymer Free Drug Eluting StentsSystem Details

Product Description

  • Nanoporous cavities on strut abluminal surface functioning as drug carrier to ensure the firm adhesion.
  • Vacuum drug coating technology ensures complete drug dosage and coating stability.
  • Post-treatment after drug loading helps with sustained drug release.
  • Soft tapered tip provides smooth transition from guidewire to balloon catheter and excellent crossability.
  • Short shoulder design at both ends of the balloon ensures the accurate dilation to the lesion, and reduces the damage to normal vessel next to the lesion.
  • Patented hydrophilic coating on distal shaft provides outstanding pushability.

  • Polymer-free design significantly reduces the inflammatory response after stent implantation to guarantee the long-term safety.
  • Polymer-free design facilitates earlier endothelialization which significantly shorten the DAPT time.
  • The rough strut surface helps with earlier and easier endothelialization to reduce the risk of thrombosis.

DES Efficacy [1]

BMS Safety [2]

Nano+™ OCT Study

An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety

Prouduct Features

  • Polymer-free DES
  • Nanoporous drug carrier on abluminal surface
  • Balanced strut thickness
  • High radial force
  • Sine wave + 3-3-3 link
  • Double helix structure
  • Large open cell
  • Precise positioning markers
  • Effective drug of Sirolimus
  • Vacuum drug coating technology
  • 90-day drug releasing period
  • New delivery system

Prouduct Benefits

  • Significantly shorten DAPT time
  • Earlier & better endothelialization
  • Highly reduced risk of thrombosis
  • Great deliverability
  • Easy positioning and placement
  • Optimal tissue scaffolding
  • Excellent side branch access
  • Scientific drug releasing period

Prouduct Ranges

  • Ø 2.5 - 4.0 mm
  • 12 - 36 mm multi stent lengths

Clinical Studies

An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety [3].

In a prospective, multicentre, single-arm, open-label study, OCT examinations

were performed at three months in 45 patients (47 lesions). 23 patients with 24 lesions

had serial coronary angiography and OCT assessment at three and six months.

OCT Analyses

Coverage status of the individual stents/patients at two time points (three and six months).

Serial OCT showed almost complete vascular healing at six months, even when coverage was insufficient at three months. This suggests an adequate safety and efficacy profile of the device at that point in time.

Specifications

Technical Parameters

Stent Material

316L Stainless Steel

Strut Design

Nanoporous drug carrier on abluminal surface

Metal to Artery Ratio

15%

Recoil

< 2%

Shortening

< 1%

Crossing Profile

Ordering Information

Stent Diameter

Stent Length (mm)

(mm)

12

15

18

21

24

29

33

36

LPRPS2512

LPRPS2515

LPRPS2518

LPRPS2521

LPRPS2524

LPRPS2529

LPRPS2533

-

LPRPS2712

LPRPS2715

LPRPS2718

LPRPS2721

LPRPS2724

LPRPS2729

LPRPS2733

LPRPS2736

3

LPRPS3012

LPRPS3015

LPRPS3018

LPRPS3021

LPRPS3024

LPRPS3029

LPRPS3033

LPRPS3036

LPRPS3512

LPRPS3515

LPRPS3518

LPRPS3521

LPRPS3524

LPRPS3529

LPRPS3533

LPRPS3536

4

LPRPS4012

LPRPS4015

LPRPS4018

LPRPS4021

LPRPS4024

LPRPS4029

LPRPS4033

LPRPS4036

Provide Comprehensive Solution For

Global Patients

Fill out the form to leave inquiries. We would get back to you as soon as possible.

As one of professional medical device manufacturers in China, we have been engaged in manufacturing medical device for many years. Thus, we have confidence to benefit the people in needs through our products.



Отправить запрос, связаться с поставщиком

Кому: Lepu Medical Technology(Beijing)Co.,Ltd
Ваш E-mail:
Текст письма:


Send to other suppliers

Другие товары поставщика

Central Nervous System
Central Nervous System Central Nervous System For Central Nervous System diseases, we are developing several types of API Including Antidepressant, Anticonvulsant, etc. ...
Partner®Sirolimus-eluting Coronary Stent System
Partner®Sirolimus-eluting Coronary Stent System Partner® Sirolimus Eluting Coronary StentSystem Partner® Sirolimus-eluting Coronary Stent System details Product Features Easy positi...
Single Use Disposable Trocar and Veress Needle
Single Use Disposable Trocar and Veress Needle 45° Sleeve Tip Bevel Navigate Thread Sealing Better Application: Lepu Medical disposable trocarare suitable for establishing the wo...
Macitentan
Macitentan Item/Code CAS No. Therapeutic Area Certification/Stage API Hypertension US - DMF No.31658 China - YI) As a macitentan manufacturer and opsumit m...
LEN503 Nebulizer
LEN503 Nebulizer Cute pet caring Small atomized particles Adjustable atomizing cup High-quality compressor LEN503 Nebulizer Details Cute pet caring ...
Все товары поставщика

Похожие товары

Chlortetracycline Premix
Chlortetracycline Premix Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. Precautions for the use of Chlortetracycline Premix in livestock feed 1. Strict compliance: &midd...
Chlortetracycline Premix
Chlortetracycline Premix Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. Chlortetracycline Premix in livestock and poultry feed: 1. Purpose: · Promote the growth o...
Chlortetracycline Premix
Chlortetracycline Premix Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. Uses of Chlortetracycline Premix ·Livestock and poultry health: Chlortetracycline Premix i...
Chlortetracycline Premix
Chlortetracycline Premix Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. Characteristics of Chlortetracycline Premix ·Natural fermentation products: Chlortetracycl...
Chlortetracycline Premix
Chlortetracycline Premix Продавец: Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. Chlortetracycline Premix is a feed additive that combines chlortetracycline with premix technolog...